Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Barbara J. Desoer net worth and biography

Barbara Desoer Biography and Net Worth

Director of DaVita

Barbara J. Desoer has been one of our directors since October 2015. Ms. Desoer served as the chief executive officer and a member of the board of directors of Citibank, N.A., a wholly owned subsidiary of Citigroup Inc. and a diversified global financial services company, both positions she held from April 2014 through April 2019, and chief operating officer of Citibank, N.A. from October 2013 to April 2014. Prior to Citibank, N.A., Ms. Desoer spent 35 years at Bank of America, a diversified global financial services company, most recently as president, Bank of America Home Loans, where she led the integration of Countrywide, the largest mortgage originator and servicer in the United States. In previous Bank of America roles, Ms. Desoer served as a Global Technology & Operations executive, an international market-focused position leading teams in the United Kingdom, Asia and Latin America, and president, Consumer Products. Since April 2019, Ms. Desoer has served as chair of Citibank, N.A. and as a member of the board of directors of Citigroup, Inc. She serves on the board of visitors at the University of California at Berkeley. Ms. Desoer also has served on the board of directors of various non-profit and privately held corporations.

What is Barbara J. Desoer's net worth?: The estimated net worth of Barbara J. Desoer is at least $1.53 million as of May 10th, 2024. Ms. Desoer owns 10,954 shares of DaVita stock worth more than $1,531,588 as of May 20th. This net worth estimate does not reflect any other assets that Ms. Desoer may own. Learn More about Barbara J. Desoer's net worth.
How do I contact Barbara J. Desoer?: The corporate mailing address for Ms. Desoer and other DaVita executives is 2000 16TH STREET, DENVER CO, 80202. DaVita can also be reached via phone at (720) 631-2100 and via email at [email protected]. Learn More on Barbara J. Desoer's contact information.
Has Barbara J. Desoer been buying or selling shares of DaVita?: During the last ninety days, Barbara J. Desoer has sold $698,214.30 in shares of DaVita stock. Most recently, Barbara J. Desoer sold 5,030 shares of the business's stock in a transaction on Friday, May 10th. The shares were sold at an average price of $138.81, for a transaction totalling $698,214.30. Following the completion of the sale, the director now directly owns 10,954 shares of the company's stock, valued at $1,520,524.74. Learn More on Barbara J. Desoer's trading history.
Who are DaVita's active insiders?: DaVita's insider roster includes Joel Ackerman (CFO), Pamela Arway (Director), Charles Berg (Director), Barbara Desoer (Director), Paul Diaz (Director), John Nehra (Director), Paula Price (Director), Javier Rodriguez (CEO), Michael Staffieri (COO), Kathleen Waters (Insider), and Phyllis Yale (Director). Learn More on DaVita's active insiders.
Are insiders buying or selling shares of DaVita?: In the last year, insiders at the sold shares 6 times. They sold a total of 149,364 shares worth more than $18,246,412.06. The most recent insider tranaction occured on May, 10th when Director Barbara J Desoer sold 5,030 shares worth more than $698,214.30. Insiders at DaVita own 1.4% of the company. Learn More about insider trades at DaVita.
Information on this page was last updated on 5/10/2024.

Barbara J. Desoer Insider Trading History at DaVita

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/10/2024	Sell	5,030	$138.81	$698,214.30	10,954
5/10/2023	Sell	2,449	$101.61	$248,842.89
6/3/2022	Sell	2,320	$97.42	$226,014.40
5/13/2021	Sell	1,920	$126.01	$241,939.20	5,015
11/17/2020	Sell	1,388	$111.00	$154,068.00	1,818

Barbara J. Desoer Buying and Selling Activity at DaVita

DaVita Company Overview

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Today's Range

Now: $139.82

$137.00

$140.45

50 Day Range

MA: $135.28

$126.11

$142.21

2 Week Range

Now: $139.82

$71.51

$145.04

Volume

758,600 shs

Average Volume

831,588 shs

Market Capitalization

$12.26 billion

P/E Ratio

15.89

Dividend Yield

N/A

Beta

1.04

Protect Your Bank Account Before It’s Too Late

From Weiss Ratings | Ad

For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …

Stop right now and do these 3 things to protect yourself